Metropolitan Hospital, an esteemed healthcare institution, has garnered national recognition in the field of infection prevention and safety, joining an elite group of 338 hospitals nationwide. This significant distinction reflects the measures outlined by the Centers for Disease Control and Prevention’s National Healthcare Safety Network, recognized as the preeminent infection surveillance system in the United States.
The New York-based hospital, officially known as NYC Health + Hospitals/Metropolitan, has demonstrated exceptional performance by achieving a central line-associated bloodstream infection (CLABSI) rate of zero. This achievement is predicated on data furnished by the CMS Healthcare-Associated Infections (HAI) metrics that serve to benchmark hospital safety and infection prevention at the national level. Julian S. John, MPA, Chief Executive Officer of NYC Health + Hospitals/Metropolitan, attributes this milestone recognition to the interdisciplinary team’s unwavering dedication and expertise, which continually set patient safety standards across the nation.
Attaining a CLABSI rate of zero necessitates a holistic focus on evidence-based clinical practices within hospitals, necessitating precision in central line insertion and maintenance techniques, as well adherence to stringent infection prevention standards. The collaborative efforts across multiple institution units, including infection prevention, nursing, critical care, and quality — to evaluate device requirement, undertake maintenance audits, enhance documentation, and enforce sterile procedures are essential.
The HAI data administered by the Centers for Medicare & Medicaid Services spanning October 2023 through September 2024 showcases the frequency at which patients obtain infections during their inpatient stays compared to similar hospitals. This measurement evaluates all patient categories treated in acute care hospitals. In light of the continual rise of complex infections in the health care scene, hospitals like Metropolitan Hospital have been continuously refining and fortifying their infection prevention strategies to guarantee timely provisions and improved patient outcomes.
This is manifested in their ongoing strides in staff training, monitoring, and protocol adaptation aimed at bolstering infection prevention and patient safety. The hospital’s chief officers emphasize the importance of clinical excellence, robust protocols, real-time infection monitoring, cross-disciplinary collaboration, and a robust quality-improvement infrastructure that prioritizes patient safety at all levels.